Procaps Group, S.A. (“Procaps” or the “Company”), a leading Latin America integrated pharmaceutical and healthcare company, announces a major milestone in its transformation journey with the successful completion of a $130 million equity investment (including the previously announced secured convertible notes issued to Hoche Partners Pharma Holding S.A.) and the finalization of a comprehensive debt restructuring with its key lenders. The private capital raise was secured from Chemo Project S.A., Becaril S.A., Flying Fish Ventures L.P., Saint Thomas Commercial S.A., Santana S.A., Hoche Partners Pharma Holding S.A. and other investors. Together, these shareholders now hold approximately 90% of the Company.
Read the full article: Procaps Group Secures $130M in Equity Investment and Completes Comprehensive Debt Restructuring //
Source: https://www.globenewswire.com/news-release/2025/04/09/3058897/0/en/Procaps-Group-Secures-130-Million-in-Equity-Investment-and-Completes-Comprehensive-Debt-Restructuring-as-New-Investors-Take-Over-Strategic-Leadership.html